CRISPR Therapeutics AG (NASDAQ:CRSP)
Bands
Volume
200 SMA
50 SMA
20 SMA
Videos
Alerts
Articles
Events
Old Forum Content for CRSP
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- Cjauger: Many stocks rising from the ashes. $INMD, $FUBO, $DQ, $FIGS, $SHOP, $CRSP. Sifu @Dan and @scottrades, some of these were old favorites in the trading room. Does this represent a shift and or rotation into smaller tickers? There are many more
- djgustoso: @Cjauger $CRSP I finally couldn't take the pain of this one anymore and sold it all two days ago, hence marking the bottom of the stock for everyone else lol, all aboard!
- scottrades: @djgustoso $CRSP LOL! We've all been there.
- Cjauger: @djgustoso $CRSP Been there done that. 😂
- pperlroth: Any thoughts on $CRSP bouncing off the 50dma? I have a little and would like a lot.
- Henry: @pperlroth $CRSP @Woodman is our bio guru, I know nothing of their pipeline or fundies. However looking at the chart it has been range bound for 2 years. A move from here to the top of the range would be 25% and one could say it made a higher low. The 50 ema is below the 200 ema and the stock price is between the two. Dan used to speak a lot more about the importance of the weekly chart. Has he changed his mind or just has a different approach to teaching? IDK
- woodman: @Henry @pperlroth $CRSP - Thanks, Henry, LOL. I'm not a "bio guru"; I just play one on TV. And to prove that, I have nothing to contribute regarding CRSP or really any of the gene editing stocks these days. I used to follow many of them, but that was too long ago for me to be any help here. My apologies. @pperlroth, if you find anything good, please let us know. Thanks.
- natural: $CRSP has been hammered these past few weeks. Looks like selling is nearly done and the stock is making a slow turn. One to watch, IMHO.
- JosephM: $CRSP - reversal
- natural: @JosephM $CRSP Near 20% short interest, 13 down days in a row all the way to the 50 day. I'm long calls.
- Cjauger: @natural was just looking at that, $CRSP right at the 50
- natural: $CRSP has marched all the way back to the 50day
-
DAN: ...
"06:35 PM 02/27/2024 @X802tp01@Dan I just joined and been enjoying the trading room and learning a lot. I have a position in $CRSP. Looking at the chart it has a year long base bumping back up to the top of the range. It has gotten recent appro ... - X802tp01: @Dan I just joined and been enjoying the trading room and learning a lot. I have a position in $CRSP. Looking at the chart it has a year long base bumping back up to the top of the range. It has gotten recent approval for its gene editing technology and trying to get approval for other uses. Biotech is breaking out. Would it make sense to add to my position around 90.50?
- moneybag: $CRSP makes another 52 week high on earnings
- moneybag: $CRSP continues higher up 10%
- moneybag: $CRSP just blew through 52 week high
- moneybag: $CRSP
- moneybag: $CRSP closed up 9% today on higher than average volume and closed strong near the high of the day. Long ..until Dan tells me I'm crazy..
- moneybag: $CRSP !!
- moneybag: $CRSP breaking out here
- chrisbman360: @moneybag $CRSP This has been in a long squeeze since late Dec. I've been picking up shares with bounces off the 50d. Been waiting for some breakout. Maybe this is it. Maybe not.
- bigreek42: $crsp looks strong today kind of squeezing?
- chrisbman360: $CRSP been sitting in a squeeze for awhile. All ma bunched together. Earnings another month out. Watching this one.
- BarryC: Trying some $CRSP
- BarryC: A friend just told me that there is some pending FDA stuff going on with $CRSP. I had NO IDEA... SO BE CAREFUL!!!!!!!!!!!!! VERY SPECULATIVE!!!!!
- bill52: @BarryC $CRSP Crispr just recently received approval in the UK for its crispr technology to treat sickle cell anemia which is the first ever approval for this type of therapy to treat a disease at its source in the DNA (fix the problem, not just treat the symptoms). The US FDA is expected to announce its verdict if it will be allowed in the US on Dec 8. Here's the article: https://www.investors.com/news/technology/crsp-stock-surges-after-winning-the-first-ever-crispr-gene-editing-approval/?src=A00220
- BarryC: @bill52 $CRSP Tyvm.... Thats WAY over my pay-grade. I'll stick to what @Dan taught me best, The Chart :-)
- wineinquirer: @BarryC $CRSP The FDA is making the "decision" for approval of the first US genetic treatment for sickle cell disease by Crispr & Vertex pharm, Exa-cel, on Friday (recently approved in the UK under the name Casgevy). They're also considering a second indication for the drug for another blood disorder. The ramp up in Crispr price since Nov 1rst (a mere 80%) likely reflects the positive approval this Fri so may see a sell the news after such a price gain. Just my opinion. BTW, many thx for all you share with members.
- bill52: $CRSP $VRTX Just my opinion but I think this is truly ground breaking and fascinating stuff for how diseases will be dealt with in the future. CRSP and VRTX partnered for the first ever approval of two therapies in the UK and expect approvals in the US in December. I'm not a doctor but sounds like you treat the problem at the DNA source and not just the symptoms. Here's one of the articles in IBD. https://finance.yahoo.com/m/4ce79342-7898-39b9-9cba-3697eeac8c6e/crispr-surges-after-winning.html
- DAN: @bill52 $CRSP $VRTX I agree with you, bill. CRISPR gene editing is really cutting edge and important stuff. It can do a lot of good.
- Docoof: $CRSP $ARKG First CRISPR gene-editing filings to be accepted for review by FDA - - FDA grants Priority Review for severe sickle cell disease (SCD) and Standard Review for transfusion-dependent beta thalassemia (TDT) – - PDUFA target action date of December 8, 2023, for SCD and March 30, 2024, for TDT – https://www.businesswire.com/news/home/20230608005819/en/FDA-Accepts-Biologics-License-Applications-for-exagamglogene-autotemcel-exa-cel-for-Severe-Sickle-Cell-Disease-and-Transfusion-Dependent-Beta-Thalassemia
- DanAz: $CRSP Watching
- DAN: $ARKK -- Some of the holdings in $ARKK are working pretty well this morning: $DNA $TWST(strong upside momentum) $PLTR (Still defying gravity) $CRSP (Close to breaking $70) I like $ARKK because it trades a bit smoother and is easier to manage. But you action junkies can find a lot here.
- Docoof: $ARKK Arkk stocks having a strong day: $TWLO $DKNG $PATH $SHOP $ROKU $CRSP $U $COIN —$ARKK currently at $39.94 up 3.2%.
- Docoof: @jpoko13 $ARKK Many of its top holdings are doing well today: $TWLO $DKNG $PATH $SHOP $ROKU $CRSP $U $COIN $TDOC $NTLA
- BarryC: $CRSP Worth Watching
- sgiseller: $CRSP has caught a nice bid today. A long term hold for me. This is why A decade ago, altering specific sequences of genomic human DNA with the CRISPR/Cas9 platform was nothing more than an interesting idea. Last month, CRISPR and partner Vertex Pharmaceuticals (VRTX 0.06%) completed the rolling submission of the Biologics Licensing Applications for exagamglogene autotemcel (exa-cel) for the rare blood disorders sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). Exa-cel is an autologous, ex vivo CRISPR/Cas9 gene-edited therapy that enables a patient's hematopoietic stem cells to produce high levels of fetal hemoglobin in red blood cells. The fact that this cutting-edge tech progressed all the way from an intriguing concept to a potential game-changing therapy for SCD and TDT in roughly 10 years' time is a testament to the unique talents of CRISPR's clinical team and upper management.
- woodman: @sgiseller $CRSP - the gene-editing & therapy/CAR-T stocks were pretty lively today. $NTLA leading the pack.
- woodman: @sgiseller $CRSP - Thanks for the info. I can't believe I let $VRTX get away. I held it for a good while.
- Docoof: @sgiseller $CRSP Very good post. Thanks.
- sgiseller: @woodman $CRSP $NTLA totally Missed $NTLA, and there it was on my scan...I get sidetracked easily
- joelsg1: @sgiseller $CRSP $NTLA I keep a running notebook, and sometimes can read my writing.
- sgiseller: $CRSP Mentioned an add April 13th, up over 7% today, %2B 23% in last 5 days this should benefit from merk's acquisition and biotech trends
- Kid2old: @scottrades $ARKK $CRSP – NEWS 4/6/23 Cathie Wood loads up on Biotech stocks. Funds operated by ARK bought shares of Crispr Therapeutics AG ($CRSP), Intellia Therapeutics Inc ($NTLA), Verve Therapeutics Inc ($VERV), Beam Therapeutics Inc ($BEAM) and Ginkgo Bioworks Holdings Inc ($DNA). The purchase was conducted via the flagship ARK Innovation ETF ($ARKK) and the ARK Genomic Revolution ETF ($ARKG).
- sgiseller: $CRSP in a bit early, This is a long position for me. IMHO This technology will be a game changer ADDED today
- sgiseller: $COIN $VVNT $CRSP catching bids have small positions in all
- sgiseller: @sgiseller $COIN $VVNT $CRSP SOLD $COIN @ 66.58, looking to reload
- joelsg1: $CRSP Follow through day and I'm looking for pb entry, but today is est. tax payment day, tomorrow quad witch and Monday start of #LarryWilliams decline through end of month, so watchful waiting. Np yet.
- bill52: $CRSP a previous active trade that is looking more productive today with a move above the 50dma, but needs to contend with the 200dma looming above around 73. I'm just watching for now, but a solid close at 73+ would possibly be actionable. $RBLX has a somewhat similar look and worth watching.
- joelsg1: @bill52 $CRSP $RBLX Nice idea and analysis. I usually use the simple rather than exponential moving avgs. but look at the difference in this chart. On the simple, the 200d is $5 below whereas on the ema it's $2 above. Don't forget the weekly, where the 20w sma held. :)
- bill52: @joelsg1 $CRSP $RBLX Excellent point and I should have been clearer on which moving average i was looking at. Yes, the weekly looks good for that.
- joelsg1: $CRSP Volume into close.
-
DAN: ...
Look at $LNTH $CRSP $SFIX $XBI $DQ $QLD $SSO. These are all positions that were open but have since been closed for either a profit or loss. But all of these charts are instructive. What happened AFTER the trade was closed. Was it right to close ... -
DAN: ...
$CRSP -- Still consolidating. Alert $84.40
$CHPT -- Breakout today. Strong close. @champ’s idea today.
$DNUT -- Good squeeze possibilities on a move above $14.85 Alert $14.85
- slp20:
- jaaron2: Any feedback regarding the following would be appreciated: buying $LIT instead of ALB or SQM with stop at 77.41 adding to $IWM with stop at 193.11 Buying $XBI instead of $CRSP or $EXAS or $VRTX with stop at 91.40 Buying $ARKK with stop at 49.05 Buying $CELH with stop at 96.61 I am new to SMM so any feedback highly appreciated. Thank you humbly.
- Amisure: @jaaron2 $LIT $IWM $XBI $CRSP $EXAS $VRTX $ARKK $CELH - If I review my trading mistakes. I often find I bought stocks that are going up- but after they are already up a bit. So I buy up trending stocks but to late- then they correct. "buying after a zig then a zag happens". many of your buys here look like this.
- Docoof: @jaaron2 $LIT $IWM $XBI $CRSP $EXAS $VRTX $ARKK $CELH $LIT seems ok w/stop below the 200d sma. Above 80.50 and it’s above that resistance line that can be drawn from Feb2.
-
DAN: @jaaron2 $LIT $IWM $XBI $CRSP $EXAS $VRTX $ARKK $CELH
None of these are "perfect" entries, but here are my thoughts re/ risk:
LIT -- I think y our stop is too tight. You'll probably get stopped out.
IWM -- same. Stop is too tight.
XBI ... - joelsg1: @jaaron2 $LIT $IWM $XBI $CRSP $EXAS $VRTX $ARKK $CELH What everyone else said, but when setting stops below a recent low, pick a last digit number below a round number, so instead of 77.41 which is just above round number .40, pick 77.34, less likely to be hit. Also, learned from @Scottrades select GTC good until cancelled instead of Day for stop duration, supposedly scanning programs can't detect GTC stops (Hope that's true).
- jaaron2: @DAN $LIT $IWM $XBI $CRSP $EXAS $VRTX $ARKK $CELH Thank you Dan, I am learning. Thank you for all your input. Humbly I am not as skilled as the many other folks on your forum. So I appreciate your input. JD
- DAN: @jaaron2 $LIT $IWM $XBI $CRSP $EXAS $VRTX $ARKK $CELH That means that you are in the right place! You are going to do quite well with the attitude you have. Great to have you here! 8-)
- ar2006: @scottrades What do you think about $CRSP and $CNC?
- scottrades: @ar2006 $CNC Looks like a positive Earnings Reaction, but a bit extended. $CRSP - Nice to see it hold above the 21 EMA. Short term support about 7% down.
-
DAN: ...
$CRSP -- stopped out. Avoid.
$LNTH -- Stopped out of the tight stop (68.70). I would not hold this here. No potential upside at this time.
$LCID -- Stopped out of the 19.85 tight stop. $18.93 still intact. Stagnating here.
$QLD -- reversing toda ... -
DAN: ...
$CRSP -- stopped out. Avoid.
$LNTH -- Stopped out of the tight stop (68.70). I would not hold this here. No potential upside at this time.
$LCID -- Stopped out of the 19.85 tight stop. $18.93 still intact. Stagnating here.
$QLD -- reversing toda ... - DAN: Morning Market Update Good morning. Stocks are opening higher this morning after really solid gains on Tuesday and Wednesday. It's still too early to conclude that we've seen the low of the year, but I do like the way things are shaping up. since last Thursday, the % of stocks above their 40-day moving average have increased by 150%. So, we're seeing some concerted buying across sectors. Stops on Open Active Trade Ideas: $CRSP - 79.80 $LNTH - 68.70 $LCID - 19.85 $QLD - 46.45 $SSO - 46.70 $IWM - 171.50 $ARKK - 45.90 Have a great day, and be disciplined in your trading activity. --Dan
-
DAN: ...
$CRSP -- In consolidation mode. Heavy volume today on what looks like an intraday reversal. Peak after 10 am.
$LCID -- Stop at 19.85. Alert $19.85
$QLD -- raising the stop from 43.65 to $44.90. This might be too tight for you. Alert $44.90
$SSO ... -
DAN: ...
$CRSP -- stop was hit at 79.80. But this trade is still working. If you’re still long, let it work. The 8-day moving average defines the short-term uptrend. The weekly chart is best for the longer term trend following -- watching for higher ... - jgg8387: $CRSP - @Dan I am a little surprised to note that $CRSP is still in the Active Trade List, because on Friday morning Dan reiterated the Stop at 79.80 and said "the Stop was hit, honor the Stop." I suppose the smart folks may not have stopped out all of their position, but I haven't found any message from Dan saying Buy CRSP again. I'm not criticizing Dan, just pointing out what seems to be an inconsistency. Of course, I'm also wishing I hadn't been stopped out of my whole position or that I wasn't active enough on Friday to buy it back. That's trading. I hope everyone has a good day trading. Joe
- DAN: The 79.80 stop on CRISPR Therapeutics ($CRSP) was hit. Honor your stop. --Dan
- jpoko13: @DAN $CRSP I believe the stop was moved up earlier this week and so the stop was triggered on Wednesday and I honored it then.
- DAN: @jpoko13 $CRSP Thanks jpoko13. I forgot about that. Not one that we'd want to be in right now, though definitely worth watching.
- jpoko13: @DAN $CRSP See? I'm paying attention. :)
- DAN: @jpoko13 $CRSP LOL. Now, if I could only pay attention. ;-)
-
DAN: ...
$CRSP -- Active Trade. In at $82. Stop at 79.80.
$HCSG -- VERY SPECULATIVE. Box trade. Basis: $18.49 Stop: $17.90. Earnings Wednesday. Trading a volatility squeeze. Alert $18.70
$DLTR -- Breakout? Might be a fakeout. Could have bought at $170 ... - Cjauger: $CRSP was stopped out yesterday, looking good today
-
DAN: ...
$CRSP remains active, with a cost basis of $82, and a stop at 79.80.
--Dan - jpoko13: @DAN $HAE $MRNA $ZM $CRSP The stop was hit yesterday according to Fidelity. :( $CRSP
- jonwest88: @jpoko13 $HAE $MRNA $ZM $CRSP Yes the stop was first listed as $80. I set mine at 79.75 and got taken out.
- DAN: Adding CRISPR Therapeutics ($CRSP) to the Active Trade List. The breakout was at $80, and it's up just 3% above that level. Use a tight stop -- just below $80 bucks. If you are taking the trade, start SMALL. Basis: $82.00 Stop: $79.80 Careful here. Breakouts have been tough. --Dan
- woodman: @DAN $CRSP - See also #Gene #Car-T stock list for a number of good performers.
- Cjauger: Bought $SNOW and $CRSP small
- wineinquirer: @DAN $CRSP $VRTX 11:27 AM 07/13/2022$CRSP $VRTX @Dan......$CRSP has partnership w/$VRTX which displays a 1.8y cup and a 3mo W handle. Been watching $VRTX since April (along w, $CRSP inv H&S). Would prefer >300 barrier to reduce risk but very sm position here could be rewarding as long as you account for risk. Like your respect of risk w/$CRSP. Encouraging pattern but could still see pb to bo in this wild and crazy mkt! Thx for your above and beyond energy as you work on healing the knee. Been there with a hip. It can be beaucoup challenging to brain function!!
-
DAN: ...
$CRSP -- Just added today (basis: 82; stop: 79.80)
However, recent stocks that have hit stops are finding support. I actually view these as lower risk trades now because they are bouncing off support rather than breaking out. Check these out:
$R ... - jpoko13: @DAN $HAE $MRNA $CRSP $RBLX $ZM $HALO $NTLA $TAN $JKS $CLFD $TDOC $ENPH $DQ $OLLI I believe the change you made in the stop on $MRNA actually stopped it out this morning. Did mine. :(
- jonwest88: $CRSP hit that stop @79.74 pretty quick. The couple uh hour trade. Puny loss
- Nepenthe: @jonwest88 $CRSP Yep, that didn't last long. So out of spite, I bought it back. So far so good. Cheers.
- DAN: @jpoko13 $HAE $MRNA $CRSP $RBLX $ZM $HALO $NTLA $TAN $JKS $CLFD $TDOC $ENPH $DQ $OLLI Sorry about that. Keeping it on the list.
- vcondry: Ugly-ish day... lone standout to the upside for me $CRSP
- scottrades: @vcondry $CRSP Seeing $XBI Holding up ok today. Whippy but still above the MAs for now.
- Docoof: $ARKK’s Top 10 holdings added to ATL: #1 $ZM (ARKK’s largest pos.) #5 $TDOC #8 $NTLA #3 $CRSP Discussed but not added. [#15 $RBLX]
- woodman: This is a list of #Gene editing/therapy #Car-T stocks (#Biotech subset). I haven't updated it in some time, so it's not an up-to-date/complete list, but it provides a number stocks that are acting very well and, if you've paid any attention to this area over the years, you'll certainly recognize many of them (including $NTLA which @Dan added to his list today). If interested, kick some of their tires over the weekend (listed below in order of performance today). $ABEO $ADVM $EIGR $PGEN $QURE $RARE $AGTC $SRNE $BLUE $PRTA $CLLS $AVRO $MGTX $ADAP $KRYS $SRPT $BMRN $AMGN $ARCT $RGNX $CNCR $SLDB $TCRT $AGIO $NVS $JNJ $PFE $IOVA $NTLA $SGMO $LUMO $EDIT $VYGR $ORTX $CRSP $BLCM $BBIO
- DAN: My Notes: SS 070722 COTD: Here’s your trade on Zoom Media ($ZM). $SPY -- 4th consecutive day of higher closes, and 5th day relative to the open. Look for more basing and potential upside. Be cautious and observant rather than blindly bearish. $XBI -- Best of the bunch. Lots of potential trades here. Look at stocks like $CTIC -- watch this? $CRSP -- Active Trade List Candidate? $MRNA -- Active Trade List Candidate? Ticker -- Basis -- Stop $HAE - 67.25 -- 59.90 Alert $59.90 $BABA - 120.79 - 110.00 Alert $110 $DQ - 68.14 - 63.00 Alert $63 $FXI - 33.76 - 29.50 Alert $29.50 $WB - 23.07 - 21.50 Alert $21.50 $BIDU - 150.72 - 144.00 Alert $144 $HALO - 48.50 - 43.00 Alert $43 $JKS - 73.90 - 65.20 Alert $65.20 $TDOC - 41.90 - 37.90 Alert $37.90 $TAN - 75.36 68.50 Alert $68.50 $ARKK -- tomorrow? Alert $47 $RBLX tomorrow? Alert $40.00 $NTLA -- soon? Alert $65.10 $ZM -- tomorrow? Alert $122 $CRSP -- Active Trade List Candidate? Alert $80 $MRNA -- Active Trade List Candidate? Alert $173.80
- woodman: Keeping with the #Biotech theme, #Gene editing/therapy / #Car-T stocks doing well. @Dan mentioned $CRSP. Many more in the group look good as well. I'll post some later when I have time.
- Babutters: @woodman $CRSP #Biotech #Gene #Car-T I entered $INBX this morning on a day trade after seeing your AH post. Closed EOD (couldn’t stare at phone). Passing over a thank you.
- Docoof: @Pokersmith $ARKK Especially 9th biggest pos. $NTLA Also #4 $CRSP
- bwcarnation1: $CRSP tanking didn't see any news yet
- scottrades: @bwcarnation1 $CRSP Looks like they are doing a presentation right now and people didn't like the cancer drug prelim. data.
| Stock Price | $47.88 |
| Change | 3.43% |
| Volume | 1,503,540 |
CRISPR Therapeutics AG is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics.
Request Video of CRSPAlready a member? Sign in here.
Past Month
Leading Peers
-
$18.38 206.54%
-
$16.00 124.00%
-
$6.12 111.84%
Past Month
Lagging Peers
-
$7.01 -94.14%
-
$6.44 -58.50%
-
$8.89 -57.76%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!